Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease
| Autor: | Jason K. Burris, Andrew P. Cap, Prajeeda M Nair, Kristin M Reddoch-Cardenas, Michael A. Meledeo, Matthew Rendo |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.drug_class
Immunoglobulins Article 03 medical and health sciences Plasma 0302 clinical medicine Immune system medicine Humans Blood Transfusion Clotting factor Factor VIII biology business.industry Anticoagulant Fibrinogen Hematology medicine.disease Hematologic Diseases Blood Coagulation Factors Hematologic disease 030220 oncology & carcinogenesis Hemostasis Cryoprecipitate Immunology biology.protein Fresh frozen plasma Antibody business 030215 immunology |
| Zdroj: | Seminars in Hematology |
| ISSN: | 1532-8686 |
| Popis: | Hematologic diseases include a broad range of acquired and congenital disorders, many of which affect plasma proteins that control hemostasis and immune responses. Therapeutic interventions for these disorders include transfusion of plasma, cryoprecipitate, immunoglobulins, or convalescent plasma-containing therapeutic antibodies from patients recovering from infectious diseases, as well as concentrated pro- or anticoagulant factors. This review will focus on recent advances in the uses of plasma and its derivatives for patients with acquired and congenital hematologic disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|